1) Sontum, P.C.:Physicochemical characteristics of Sonazoid(TM), a new contrast agent for ultrasound imaging. Ultrasound Med. Biol., 34:824-833, 2008.
2) Toft, K.G., Hustvedt, S.O., Hals, P.A., et al.:Disposition of per fluorobutane in rats after intravenous injection of Sonazoid(TM). Ultrasound Med. Biol., 32:107-114, 2006.
3) ソナゾイド注射用16μl添付文書.
4) Watanabe, R., Matsumura, M., Chen, C.J., et al.:Characterization of tumor imaging with microbubble-based ultrasound contrast agent, Sonazoid, in rabbit liver. Biol. Pharm. Bull., 28:972-977, 2005.
5) Watanabe, R., Matsumura, M., Munemasa, T., et al.:Mechanism of hepatic parenchyma-specific contrast of microbubble-based contrast agent for ultrasonography-Microscopic studies in rat liver. Invest. Radiol., 42:643-651, 2007.
6) Wake, K., et al.:Cell biology and kinetics of Kupffer cells in the liver. Int. Rev. Cytol., 118:173-229, 1989.
7) Moriyasu, F., et al.:Efficacy of perflubutane microbubble-enhanced ultrasound in the characterization and detection of focal liver lesions:Phase 3 multicenter clinical trial. AJR, 193:86-95, 2009.
8) 社内研究報告書.
9) 森義弘, 他:超音波造影剤ペルフルブタンの臨床上の安全性ならびに有用性の検討. 超音波医学, 38(5):541-548, 2011.